Our Tools. Your Health.

The next generation of cures starts with facilities built by members of North America’s Building Trades Unions

Pennsylvania
Pennsylvania
This state is considering legislation that would threaten innovation and jobs. Learn more!
Act Now! >

PILMA’s Labor Members

International Association of Fire Fighters

International Brotherhood of Boilermakers

International Association of Bridge, Structural, Ornamental and Reinforcing Ironworkers

Sheet Metal, Air, Rail and Transportation Workers

United Association

North America’s Building Trades Unions

International Union of Police Associations

International Union of Operating Engineers

International Brotherhood of Electrical Workers

PILMA’s Company Members

Pfizer

Eli Lilly & Co.

GlaxoSmithKline

Bayer Healthcare Pharmaceuticals

North America’s Building Trades Unions

Biogen

Novartis

Merck & Co.

PhRMA

Astellas

AstraZeneca LP

Johnson & Johnson Inc.

The pharmaceutical industry recognizes that the most highly skilled workers are needed to construct and maintain the highest quality research and manufacturing facilities. That is why they rely on North America’s Building Trades Unions to build and retrofit their facilities – they know they can depend on them to do the job on time, on budget and right the first time.

America’s Building Trades Unions spend more than $1 billion training their members each year. With state-of-the-art training facilities all over the country, the building trades are ready to meet the needs of today and the challenges of tomorrow. They lay the foundation that supports the biopharmaceutical industry’s quest to discover groundbreaking treatments and cures for a healthy America.

Important Issues to know:

trans·par·en·cy –  Legislation requiring disclosure of proprietary and trade secret information, such as specific pricing, marketing and research and development information of biopharmaceuticals.

PILMA warns there are unintended consequences with this type of legislation, including chilling of innovation and capital construction projects with no clear benefits to patients.

Read more about our position here.

im·por·ta·tion – Legislation that would allow the bringing of biopharmaceuticals from other counties into the U.S.

PILMA believes that there is no way to guarantee the safety and ingredients of imported medicines, further, this practices will erode U.S. jobs in the biopharmaceutical industry.

Read more about our position here.

“The industry relies on the trades to build, maintain and retrofit their facilities. In order to meet the rigorous standards of the biopharmaceutical manufacturers, our training centers align curriculum to the need of the industry. The development of new life saving drugs depends on this key relationship.”

Eric Dean
PILMA Chairman
President, Ironworkers International

“Our commitment is to the safety and quality of the products that we sell. We need companies with strong reputations and a qualified workforce. When you pay for quality, the investment comes back to you.”

Don Bohn
PILMA Vice Chairman
VP Global Government Affairs, Johnson & Johnson